ANVS · NYSE
Annovis Bio (ANVS) Stock Price & Fundamentals
Annovis Bio (ANVS) closed at $972.95 on Oct 9, 2026, up 0.97% from the previous close of $963.61.
Share price, past year
1Y +41.50%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $972.95 |
| Sep 30, 2026 | $920.39 |
| Aug 31, 2026 | $870.47 |
| Jul 31, 2026 | $829.32 |
| Jun 30, 2026 | $844.68 |
| May 29, 2026 | $801.25 |
| Apr 30, 2026 | $806.80 |
| Mar 31, 2026 | $778.01 |
| Feb 27, 2026 | $793.93 |
| Jan 30, 2026 | $816.61 |
| Dec 31, 2025 | $756.09 |
| Nov 28, 2025 | $729.75 |
| Oct 31, 2025 | $686.82 |
Key statistics
- Market cap
- $41.45B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- −$49.52M
- Shares outstanding
- 42.6M
- Dividend yield
- —
- 52-week range
- $668.90 – $972.95
Annovis Bio's market cap is $41.45B, based on a share price of $972.95 and 42.6M shares outstanding as of Jun 30, 2026.
Financials
Annovis Bio reported revenue of $0.00 for fiscal 2025.
Annovis Bio reported a net loss of $28.85M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $0.00 | — | −$28.85M | — | −$1.40 | — |
| FY2024ended Dec 31, 2024 | $0.00 | — | −$24.59M | — | −$2.31 | — |
| FY2023ended Dec 31, 2023 | $0.00 | — | −$56.20M | — | −$6.23 | — |
| FY2022ended Dec 31, 2022 | $0.00 | — | −$25.33M | — | −$3.10 | — |
| FY2021ended Dec 31, 2021 | $0.00 | — | −$14.49M | — | −$1.90 | — |
| FY2020ended Dec 31, 2020 | $0.00 | — | −$5.46M | — | −$0.87 | — |
| FY2019ended Dec 31, 2019 | $0.00 | — | −$990.98K | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2026ended Mar 31, 2026 | $0.00 | −$17.61M | −$0.63 |
| Q1 FY2025ended Mar 31, 2025 | $0.00 | −$5.54M | −$0.32 |
| Q1 FY2024ended Mar 31, 2024 | $0.00 | — | −$0.72 |
| Q1 FY2023ended Mar 31, 2023 | $0.00 | — | — |
| Q1 FY2022ended Mar 31, 2022 | $0.00 | — | — |
| Q1 FY2021ended Mar 31, 2021 | $0.00 | — | — |
| Q1 FY2020ended Mar 31, 2020 | $0.00 | — | — |
Company profile
- Name
- Annovis Bio, Inc.
- Ticker
- ANVS
- Exchange
- NYSE
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 101 Lindenwood Drive, Suite 225, Malvern, PA 19355
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001477845
Recent SEC filings
- Aug 14, 2026
- Aug 14, 2026
- Jul 10, 2026
- Jun 17, 2026
- May 20, 2026
- May 15, 2026
- May 15, 2026
- Apr 10, 2026
Frequently asked questions
What is Annovis Bio's stock price?
Annovis Bio (ANVS) closed at $972.95 on Oct 9, 2026, up 0.97% from the previous close of $963.61.
What is Annovis Bio's market cap?
Annovis Bio's market cap is $41.45B, based on a share price of $972.95 and 42.6M shares outstanding as of Jun 30, 2026.
How much revenue does Annovis Bio make?
Annovis Bio reported revenue of $0.00 for fiscal 2025.
Does Annovis Bio pay a dividend?
Annovis Bio's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Annovis Bio, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures